Fitness of drug-resistant malaria parasites

David Walliker, Paul Hunt, Hamza Babiker

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Drug-resistant mutant forms of an organism are likely to be less fit than their wild-type strains in the absence of selection. Experimental work on prokaryotic organisms suggests that this is the case, but that compensatory mutations may occur which restore the fitness of mutants to that of sensitive forms. Here, we review experimental and field studies on this subject in malaria. In the rodent model Plasmodium chabaudi, a pyrimethamine-resistant mutant has been found to grow more slowly in mice than its drug-sensitive progenitor; however, following passage in the absence of the drug it grew faster, suggesting the occurrence of compensatory mutations. Similar findings were made with a chloroquine-resistant mutant. Field studies on Plasmodium falciparum have provided circumstantial evidence of a loss of fitness of chloroquine-resistant mutants, which appear to become less frequent in the parasite population following withdrawal of the drug. However, the occurrence of frequent recombination in the life-cycle of this parasite means that in natural conditions, a gene conferring resistance, once it has arisen, can then spread into a diversity of genetically distinct backgrounds which will influence its fitness and capacity to survive in the parasite population.

Original languageEnglish
Pages (from-to)251-259
Number of pages9
JournalActa Tropica
Volume94
Issue number3 SPEC. ISS.
DOIs
Publication statusPublished - Jun 2005

Fingerprint

malaria
Malaria
Parasites
parasites
drugs
mutants
Chloroquine
chloroquine
Pharmaceutical Preparations
Organism Forms
Plasmodium chabaudi
Pyrimethamine
Mutation
pyrimethamine
mutation
Plasmodium falciparum
Life Cycle Stages
Genetic Recombination
Population
organisms

Keywords

  • Drug-resistant mutants
  • Fitness
  • Plasmodium chabaudi
  • Plasmodium falciparum
  • Wild-type strains

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

Fitness of drug-resistant malaria parasites. / Walliker, David; Hunt, Paul; Babiker, Hamza.

In: Acta Tropica, Vol. 94, No. 3 SPEC. ISS., 06.2005, p. 251-259.

Research output: Contribution to journalArticle

Walliker, David ; Hunt, Paul ; Babiker, Hamza. / Fitness of drug-resistant malaria parasites. In: Acta Tropica. 2005 ; Vol. 94, No. 3 SPEC. ISS. pp. 251-259.
@article{201a5f30f3d34e0ca3005c2a82f95ce7,
title = "Fitness of drug-resistant malaria parasites",
abstract = "Drug-resistant mutant forms of an organism are likely to be less fit than their wild-type strains in the absence of selection. Experimental work on prokaryotic organisms suggests that this is the case, but that compensatory mutations may occur which restore the fitness of mutants to that of sensitive forms. Here, we review experimental and field studies on this subject in malaria. In the rodent model Plasmodium chabaudi, a pyrimethamine-resistant mutant has been found to grow more slowly in mice than its drug-sensitive progenitor; however, following passage in the absence of the drug it grew faster, suggesting the occurrence of compensatory mutations. Similar findings were made with a chloroquine-resistant mutant. Field studies on Plasmodium falciparum have provided circumstantial evidence of a loss of fitness of chloroquine-resistant mutants, which appear to become less frequent in the parasite population following withdrawal of the drug. However, the occurrence of frequent recombination in the life-cycle of this parasite means that in natural conditions, a gene conferring resistance, once it has arisen, can then spread into a diversity of genetically distinct backgrounds which will influence its fitness and capacity to survive in the parasite population.",
keywords = "Drug-resistant mutants, Fitness, Plasmodium chabaudi, Plasmodium falciparum, Wild-type strains",
author = "David Walliker and Paul Hunt and Hamza Babiker",
year = "2005",
month = "6",
doi = "10.1016/j.actatropica.2005.04.005",
language = "English",
volume = "94",
pages = "251--259",
journal = "Acta Tropica",
issn = "0001-706X",
publisher = "Elsevier",
number = "3 SPEC. ISS.",

}

TY - JOUR

T1 - Fitness of drug-resistant malaria parasites

AU - Walliker, David

AU - Hunt, Paul

AU - Babiker, Hamza

PY - 2005/6

Y1 - 2005/6

N2 - Drug-resistant mutant forms of an organism are likely to be less fit than their wild-type strains in the absence of selection. Experimental work on prokaryotic organisms suggests that this is the case, but that compensatory mutations may occur which restore the fitness of mutants to that of sensitive forms. Here, we review experimental and field studies on this subject in malaria. In the rodent model Plasmodium chabaudi, a pyrimethamine-resistant mutant has been found to grow more slowly in mice than its drug-sensitive progenitor; however, following passage in the absence of the drug it grew faster, suggesting the occurrence of compensatory mutations. Similar findings were made with a chloroquine-resistant mutant. Field studies on Plasmodium falciparum have provided circumstantial evidence of a loss of fitness of chloroquine-resistant mutants, which appear to become less frequent in the parasite population following withdrawal of the drug. However, the occurrence of frequent recombination in the life-cycle of this parasite means that in natural conditions, a gene conferring resistance, once it has arisen, can then spread into a diversity of genetically distinct backgrounds which will influence its fitness and capacity to survive in the parasite population.

AB - Drug-resistant mutant forms of an organism are likely to be less fit than their wild-type strains in the absence of selection. Experimental work on prokaryotic organisms suggests that this is the case, but that compensatory mutations may occur which restore the fitness of mutants to that of sensitive forms. Here, we review experimental and field studies on this subject in malaria. In the rodent model Plasmodium chabaudi, a pyrimethamine-resistant mutant has been found to grow more slowly in mice than its drug-sensitive progenitor; however, following passage in the absence of the drug it grew faster, suggesting the occurrence of compensatory mutations. Similar findings were made with a chloroquine-resistant mutant. Field studies on Plasmodium falciparum have provided circumstantial evidence of a loss of fitness of chloroquine-resistant mutants, which appear to become less frequent in the parasite population following withdrawal of the drug. However, the occurrence of frequent recombination in the life-cycle of this parasite means that in natural conditions, a gene conferring resistance, once it has arisen, can then spread into a diversity of genetically distinct backgrounds which will influence its fitness and capacity to survive in the parasite population.

KW - Drug-resistant mutants

KW - Fitness

KW - Plasmodium chabaudi

KW - Plasmodium falciparum

KW - Wild-type strains

UR - http://www.scopus.com/inward/record.url?scp=19344362685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344362685&partnerID=8YFLogxK

U2 - 10.1016/j.actatropica.2005.04.005

DO - 10.1016/j.actatropica.2005.04.005

M3 - Article

VL - 94

SP - 251

EP - 259

JO - Acta Tropica

JF - Acta Tropica

SN - 0001-706X

IS - 3 SPEC. ISS.

ER -